JZL195
JZL195 is a potent and selective dual inhibitor of FAAH and monacylglycerol lipase (MAGL) . JZL195 has greater anti-allodynic efficacy than selective FAAH, or MAGL inhibitors, plus a greater therapeutic window than a cannabinoid receptor agonist. JZL195 may have greater potential in alleviating neuropathic pain, compared to selective FAAH and MAGL inhibitors, or cannabinoid receptor agonists.
Product Specifications
CAS Number
1210004-12-8
Product Name Alternative
JZL195 | JZL-195 | JZL 195
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 42 mg/mL. 96.89 mM
Smiles
[O-][N+] (=O) c1ccc (OC (=O) N2CCN (Cc3cc (Oc4ccccc4) ccc3) CC2) cc1
Molecular Formula
C24H23N3O5
Molecular Weight
433.46
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
4-nitrophenyl 4- (3-phenoxybenzyl) piperazine-1-carboxylate
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH030948 100 µg
Recombinant Human HIF-1 alpha/HIF1A Protein (His Tag)
Sign In for Pricing
View Details 
LY426341 100 µg
Tartrate Resistant Acid Phosphatase (ACP5) (NM_001111035) Human Over-expression Lysate
Sign In for Pricing
View Details 
